Botox injections appear to relieve severe incontinence

Posted on 2009-07-08 10:04:44 in Drug Trends | Longevity and Age Management | Musculoskeletal |

Urologists from Guy's Hospital and King's college conducted a randomized, double-blind placebo trial on 34 patients, averaging 50 years of age. All of the patients were either unable to tolerate or failed to respond to anticholenergic drugs traditionally used to help manage overactive bladder. Of the participants, 7 men and 9 women received Botox injections, while 8 men and 10 women received the placebo. "The Botox or placebo injections were administered using a flexible injection needle inside a cystoscope, a long tube that enables urologists to see inside the bladder," explains consultant urological surgeon Prokar Dasgupta from Guy's Hospital and King's College London School of Medicine. "This minimally invasive technique involved 20 injections - five in the midline posterior bladder wall, five in the left lateral wall, five in the right lateral wall and five across the dome of the bladder. In all, 200ml of Botox or placebo was administered."

The patients were assessed at the beginning of the study, as well as at 12 and 24 weeks following the injection. Each participant completed the King's Health Questionnaire, which was developed in the late 1990s to assess women with urinary incontinence. The higher the score, the lower the quality of life. Those patients who received the Botox injections reported significant improvements in terms of a number of quality of life factors. Moreover, at 12 weeks, the study was "unblinded" so that both patients and clinicians knew who had received the injections. During this extended period, participants exhibited further improvements, including improved sleep, greater energy and improved personal relationships.

Another study conducted by the Mayo Clinic in Jacksonville, FL on 25 women suffering from severe incontinence also showed that Botox appears to be a safe and potentially promising method of treatment. Similar to the UK study, all 25 participants had failed at least two oral anticholenergic therapies and were at the end of the line in terms of oral medical treatment options. However, unlike the UK study, the Mayo Clinic team delivered Botox to the bladder using direct instillation of a solution containing botulinum toxin Type A (Botox) and dimethyl sulfoxide.

According to the study authors, this novel delivery method has distinct advantages over the current standard approach of injecting the agent into the detrusor muscle through a cystoscope-based procedure. "Once the efficacy of botulinum toxin Type A for use in overactive bladder had been established, our team started looking for a way of delivering the agent that would not require a cystoscope or anesthetic," says first author Steven P. Petrou, MD, professor of urology at Mayo Clinic. "The idea for this less-invasive approach took its roots from collegial discourse and a review of the literature where DMSO was used as a carrier agent with other bladder-based medicines."

News Release: For people with overactive bladders, Botox injections can significantly improve quality of life http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=153348June 11, 2009


News Release: Botox cocktail appears to ease overactive bladder http://www.plasticsurgerypractice.com/eReport/2009-07-06_01.asp

 


Health Headlines

In a lab animal model, booming gut flora spawned by the Western diet is linked to obesity.
International study reaffirms importance of resolving the income gap between the richest and poorest people in developed countries.
Switzerland-based research team assesses the metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress hormones.
UCLA researchers find disability rates in Americans entering their 60s are on the rise, potentially fueled by the overweight/obesity epidemic.
Genetic clues to longevity discovered among a homogenous ethnic population.
Rush Alzheimer's Disease Center (USA) researchers find that a loss of muscle strength raises risk of Alzheimer’s Disease and mild cognitive impairment.
Stroke risk may rise in those with common infectious pathogens such as Chlamydia pneumoniae, Helicobacter pylori, and herpes simplex viruses.
First study in humans links bisphenol A (BPA) exposure to male sexual function problems.
Simple steps in the community can promote walking among residents.
Study finds that people who are dissatisfied with their workplace bosses not only take more sick leave, but are at increased risk of suffering a heart attack.
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health (PATH Medical), Chairs the Brain Age Workshop taking place Dec. 9, 2009. Held in conjunction with the Winter Session of the 17th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The Brain Age Workshop features presentations on Brain Mind Assessment via Neuropsychological Analysis, Movement Deficiency Syndrome, Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain Injury. View this video to learn about Dr. Braverman’s brain-based model of aging and age modulation.

International Events
See all events »